NASDAQ:EPIX - ESSA Pharma Inc.
$2.35
 $-0.17
-6.73%
4:00PM EDT
2019-04-18
ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EPIX     avg for
industry  
  avg for
sector  
42 stocks weight:  0. 27   199. 07   233. 87  
42 stocks rank:  4. 13 K 1. 43 K 1. 06 K

quick ratio:  3. 44   5. 29   1. 92  
current ratio:  3. 54   5. 64   2. 40  

1-yr high:  4. 74   114. 11   138. 85  
last close:  2. 35   87. 56   116. 78  
50-day avg:  3. 44   95. 43   123. 53  
200-day avg:  3. 25   94. 13   121. 20  
1-yr low:  0. 16   72. 67   98. 41  
volume:  4. 48 K 2. 43 M 4. 85 M
50-day avg volume:  10. 58 K 2. 72 M 4. 97 M
200-day avg volume:  8. 39 K 2. 90 M 4. 58 M

1-day return:  -5. 62 % -0. 40 % 0. 07 %
this week return:  -10. 98 % -5. 72 % -4. 11 %
12-wk return:  -42. 54 % 1. 78 % -0. 04 %
52-wk return:  1353. 04 % 10. 81 % 14. 09 %

enterprise value (EV):  10. 22 M 51. 19 B 117. 96 B
market cap:  20. 32 M 43. 00 B 104. 52 B
EBITDA:  -11. 38 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -0. 90   4. 34   13. 27  
total debt:  5. 69 M 12. 22 B 16. 66 B
debt/equity:  83. 98   46. 86   89. 46  
net income (common):  -12. 25 M 2. 20 B 4. 21 B

shares outstanding:  5. 78 M 570. 91 M 1. 24 B
shares:  2. 12 M 571. 02 M 1. 23 B
shares short:  9. 96 K 9. 93 M 16. 79 M
shares short prior month:  12. 99 K 9. 96 M 16. 58 M
short ratio:  1. 17   5. 31   3. 30  
short % of float:  0. 32 % 5. 81 % 2. 61 %
total cash/share:  1. 93   11. 13   9. 30  
total cash:  12. 17 M 6. 70 B 7. 10 B
free cash flow:  -6. 63 M 3. 58 B 4. 74 B
operating cash flow:  -10. 13 M 4. 14 B 6. 32 B

book value:  1. 07   12. 76   26. 84  
price/book:  2. 19   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  29. 16 % --- ---
1-yr mean volatility:  0. 05 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 12   2. 39   4. 08  
P/E:  -1. 11   13. 59   22. 83  
PE/G:  0. 06   -1. 46   1. 68  
growth:  -18. 14 % 126. 81 % 29. 29 %
earnings high:  -0. 00   1. 02   1. 63  
earnings avg:  -0. 00   0. 76   1. 51  
earnings low:  -0. 00   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -85. 65 % -2. 80 % 5. 29 %
return on equity:  -5324. 60 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  1. 34   1. 24   0. 93  
sharpe (1yr):  0. 12   0. 29   0. 60  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : EPIX
.        + 0 =             0 :: INITIAL WEIGHT
.   + 40.144 =        40.144 :: spline projection addition
.    x 1.432 =        57.487 :: industry recommendation factor
.    x 0.991 =        56.994 :: return on assets factor
.    x 0.468 =        26.647 :: return on equity factor
.    x 2.628 =        70.038 :: current ratio factor
.    x 1.187 =        83.166 :: quick ratio factor
.    x 1.362 =       113.262 :: short ratio factor
.    x 2.022 =       229.002 :: price-to-book factor
.    x 1.099 =       251.685 :: debt-to-equity factor
.    x 1.058 =       266.393 :: 50-day avg > 200-day avg
.    x 2.159 =       575.042 :: P/E weight
.    x 2.011 =      1156.522 :: PE/G factor
.     x 1.44 =      1665.237 :: beta factor
.     x 0.12 =       200.262 :: sharpe factor
.    x 1.312 =       262.674 :: industry 2-weeks return factor
.    x 0.986 =       259.125 :: "drift" penalty 2 days ago
.    x 0.852 =       220.804 :: "drift" penalty 3 days ago
.    x 0.912 =       201.335 :: "drift" penalty 5 days ago
.    x 0.731 =       147.192 :: largest single-day jump factor
.    x 0.067 =         9.925 :: low price factor
.      x 1.0 =         9.924 :: factor hist industry gain for week 15
.           0.0 symbols[symbol]['1Ygain'] > 4.2
.   - 25.068 =         0.268 :: add/subtract for performance
.                      0.268 :: FINAL WEIGHT for NASDAQ:EPIX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org